Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 3Unknown 2Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Thyroid Neoplasms 1Musculoskeletal Diseases 1Leukemia, Myeloid, Acute 1Glioma 1Disease 1Brain Neoplasms 1

Interventions

Docetaxel 21Radiosurgery 20Radiotherapy 17Androgen Antagonists 14Leuprolide 12Goserelin 12bicalutamide 11Prednisone 9Gonadotropin-Releasing Hormone 9Abiraterone Acetate 9enzalutamide 8Surveys and Questionnaires 8Radiotherapy, Intensity-Modulated 8Brachytherapy 8Blood Specimen Collection 8acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 7Triptorelin Pamoate 7Multiparametric Magnetic Resonance Imaging 7abiraterone 5pembrolizumab 4cabazitaxel 4Standard of Care 4Positron Emission Tomography Computed Tomography 4Metformin 4Heavy Ion Radiotherapy 4Flutamide 4Exercise 4Estramustine 4luprolide acetate gel depot 3darolutamide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Prostatic Neoplasms × Congresses as Topic × Clear all
NCT02934685 2016-11-18

IG-VMAT for Localized Prostate Cancer

Beijing Hospital

Phase 3 Unknown
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT02484339 2016-04-27

α-RT

University Hospital Freiburg

Phase 2 Unknown
274 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡